Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6190184 | Bulletin du Cancer | 2015 | 9 Pages |
Abstract
Mucosal melanomas of the head and neck (sinonasal and oral cavity) account for 1% of neoplasms, 4% of all melanomas and over 50% of all mucosal melanomas. They have a high metastatic potential. Five-year overall survival does not exceed 30%. Diagnosis may be difficult and includes adequate immunohistochemical staining. Risk factors, presentation and molecular biology are different from those of cutaneous melanomas. The mainstay of treatment is surgery and postoperative radiotherapy. Endoscopic surgery should be evaluated prospectively. Neck dissection is recommended for N0Â oral cavity melanomas, while it can generally be omitted for sinonasal melanomas. Inoperable tumors can be treated with exclusive radiotherapy. Molecular guidance for metastatic cases is a relevant option despite low level of evidence, based on the rarity of disease and low response rates to chemotherapy. c-KIT inhibitors and immunotherapy appear promising.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Idriss Troussier, Anne-Catherine Baglin, Pierre-Yves Marcy, Caroline Even, Antoine Moya-Plana, Marco Krengli, Juliette Thariat,